Company performance
Add to research
Current Price
as of Feb 11, 2025$145.34
P/E Ratio
N/A
Market Cap
$8.01B
Description
Add to research
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
Metrics
Add to research
Overview
- HQAliso Viejo, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerGKOS
- Price$145.34-3.11%
Trading Information
- Market cap$8.01B
- Float96.16%
- Average Daily Volume (1m)497,533
- Average Daily Volume (3m)537,454
- EPS-$2.96
Company
- Revenue$360.35M
- Rev growth (1yr)23.86%
- Net income-$21.41M
- Gross margin76.64%
- EBITDA margin-16.20%
- EBITDA-$15.66M
- EV$7.06B
- EV/Revenue19.61
- P/EN/A
- P/S22.20
- P/B11.98
- Debt/Equity23.50
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account